Next 10 |
Completes business combination with Lakeshore Acquisition I Corp. ProSomnus common stock will trade on Nasdaq Capital Market under ticker symbol “OSA” SAN FRANCISCO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”), a pioneer in p...
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus PR Newswire SAN FRANCISCO , Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (Nasdaq: LAAA) ("Lakeshore") today announced that its shareholders have approved all ...
Device expands ProSomnus’ suite of FDA-cleared Precision Oral Appliance Therapy Devices for treatment of Obstructive Sleep Apnea (OSA) Device is engineered to provide Medicare beneficiaries and their healthcare providers with new options for treating OSA SAN F...
SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- ProSomnus Holdings Inc. (“ProSomnus”), the leader in patient preferred medical devices for the treatment of obstructive sleep apnea (OSA), today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to ...
SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- ProSomnus, a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that the ProSomnus EVO TM Sleep and Snore Device is now reimbursable by Germany’s public health insurance system...
ProSomnus Sleep Technologies, which is set to go public in reverse merger deal with SPAC Lakeshore Acquisition I ( NASDAQ: LAAA ), has announced financing deal on Friday. The company stated it has signed definitive agreements with institutional investors of Cohanzick M...
32,219-square-foot facility will quintuple growth and create local jobs All ProSomnus medical devices are made in Pleasanton, CA, USA SAN FRANCISCO, June 28, 2022 (GLOBE NEWSWIRE) -- ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Ap...
Eight new deals announced last week. Chicken Soup acquires Redbox in a 'take-under' at a massive discount. Following Elon Musk's tweet last week, stating that the Twitter deal is temporarily on hold, Twitter shares fell as low as $40.01 on Friday, May 13, 2022. For further d...
ProSomnus®, Leader in Patient-Preferred Sleep Apnea Therapy, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition I Corp. PR Newswire ProSomnus is a pioneer of precision intraoral devices, a new option for treating mild to moderate obstru...
Lakeshore Acquisition II Corp. recently raised $69 million in a U.S. IPO. The SPAC hasn't disclosed a specific sector focus, and management doesn't have previous SPAC success. I'm on Hold for LBBB for the near term. For further details see: Lakeshore Acquisition II Secur...
News, Short Squeeze, Breakout and More Instantly...
Lakeshore Acquisition I Corp. Company Name:
LAAA Stock Symbol:
NASDAQ Market:
Completes business combination with Lakeshore Acquisition I Corp. ProSomnus common stock will trade on Nasdaq Capital Market under ticker symbol “OSA” SAN FRANCISCO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”), a pioneer in p...
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus PR Newswire SAN FRANCISCO , Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (Nasdaq: LAAA) ("Lakeshore") today announced that its shareholders have approved all ...
Device expands ProSomnus’ suite of FDA-cleared Precision Oral Appliance Therapy Devices for treatment of Obstructive Sleep Apnea (OSA) Device is engineered to provide Medicare beneficiaries and their healthcare providers with new options for treating OSA SAN F...